Authors: Kurt Mussina, MBA & Christina Kahn
ACRP Clinical Researcher | June 22, 2018

Despite the pressing need to bring novel therapies to patients with renal impairments, the development time and cost to bring new drugs and medical devices to market has actually increased over the past decade. Frenova® Renal Research is reversing this trend with F1RST Up®, a more efficient ecosystem of clinical research investigators and leaders in business and medicine. By eliminating traditional clinical trial bottlenecks and implementing a range of patient-focused protocols, Frenova is dramatically accelerating the pace of innovation.